Antigens for cancer immunotherapy

被引:127
|
作者
Neller, Michelle A. [1 ,2 ]
Lopez, J. Alejandro [1 ,2 ,3 ]
Schmidt, Christopher W. [1 ]
机构
[1] Queensland Inst Med Res, Brisbane, Qld 4029, Australia
[2] Univ Queensland, Sch Med, Herston, Qld 4006, Australia
[3] Griffith Univ, Sch Biomol & Phys Sci, Nathan, Qld 4111, Australia
基金
英国医学研究理事会;
关键词
Cancer; Immunotherapy; Antigen; Tolerance; Clinical trial;
D O I
10.1016/j.smim.2008.09.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Progress in tumor immunology has not been translated to effective immunotherapies for cancer. Most of the current effort in basic and clinical research concentrates on generating effective immune responses against model or well characterized antigens, yet vaccines targeting defined antigens have been less clinically successful than those based on whole tumor cells or their extracts. This review considers characteristics of proteins that determine how effectively they might serve as targets of immune control, and how different sources of antigens have fared in clinical trials. Crown Copyright (C) 2008 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:286 / 295
页数:10
相关论文
共 50 条
  • [1] Tumor-Specific Antigens and Immunologic Adjuvants in Cancer Immunotherapy
    Seremet, Teofila
    Brasseur, Francis
    Coulie, Pierre G.
    CANCER JOURNAL, 2011, 17 (05) : 325 - 330
  • [2] Cancer-Testis Antigens: Potential Targets for Cancer Immunotherapy
    Ghafouri-Fard, Soudeh
    Modarressi, Mohammad-Hossein
    ARCHIVES OF IRANIAN MEDICINE, 2009, 12 (04) : 395 - 404
  • [3] Cancer-Testis Antigens and Immunotherapy in the Light of Cancer Complexity
    Grizzi, F.
    Mirandola, L.
    Qehajaj, D.
    Cobos, E.
    Figueroa, J. A.
    Chiriva-Internati, M.
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2015, 34 (02) : 143 - 153
  • [4] Harnessing microbial antigens as cancer antigens: a promising avenue for cancer immunotherapy
    Zhang, Tao
    Zhang, Xilong
    Chen, Jianquan
    Zhang, Xiuwei
    Zhang, Yunlei
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [5] Parasites and cancers: parasite antigens as possible targets for cancer immunotherapy
    Darani, Hossein Yousofi
    Yousefi, Morteza
    FUTURE ONCOLOGY, 2012, 8 (12) : 1529 - 1535
  • [6] Carbohydrate antigens as targets for active specific immunotherapy
    Ragupathi, G
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1996, 43 (03) : 152 - 157
  • [7] Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy
    Vesely, Matthew D.
    Schreiber, Robert D.
    RENAISSANCE OF CANCER IMMUNOTHERAPY, 2013, 1284 : 1 - 5
  • [8] Perspectives of SEREX-defined antigens in diagnosis and immunotherapy for gastric cancer
    Wang, YW
    Gu, QL
    Liu, BY
    Zhu, ZG
    CANCER BIOLOGY & THERAPY, 2004, 3 (09) : 806 - 811
  • [9] Cancer/testis antigens: promising immunotherapy targets for digestive tract cancers
    Ai, Huihan
    Yang, Hang
    Li, Liang
    Ma, Jie
    Liu, Kangdong
    Li, Zhi
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [10] Cancer testis antigens - their importance in immunotherapy and in the early detection of cancer
    Suri, A
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (04) : 379 - 389